LDL-c: Done Deal, Next Epigenetics?
Meeting report with video, highlights and slides of a PACE-CME symposium held during ESC 2018 in Munich on the potential role of BET inhibition in the management of CVD and Diabetes - Videos and online CME will be added soon
Episodes 1-3 of 3
- LDL-c: Done Deal, Next Epigenetics?The real residual risk in patients with CVD & diabetes: The promise of epigenetics
Prof. Erik Stroes, MD
- LDL-c: Done Deal, Next Epigenetics?A clinical view on BET inhibition in targeting residual risk in CVD and diabetes
Prof Kausik Ray
- LDL-c: Done Deal, Next Epigenetics?Understanding epigenetics: The potential rationale for BET inhibition in management of CVD
Jorge Plutzky, MD
